A study published on Oncotarget , shows a possible a new pharmacological outlook to treat esophageal adenocarcinoma (EA) .The esophagus is a muscular tube that moves food and liquids from the throat to the stomach. Adenocarcinoma is one the most common types of esophageal cancer, which begins in cells that make and release mucus and other fluids. Esophageal cancer is often diagnosed at an advanced stage and the 5-year survival of esophageal adenocarcinoma (EA) remains low at around 15%.
http://www.sciencenutshell.com/muc1-a-promising-target-in-barretts-epithelium-be-and-esophageal-adenocarcinoma-ea/
MUC1: A promising target in Barrett’s epithelium (BE) and esophageal adenocarcinoma (EA).